SlideShare a Scribd company logo
1 of 5
Download to read offline
Introducing: Green Fluorescent Nanoparticle-labeled human Mesenchymal Stem Cells

  These cells add to our fluorescein, rhodamine and GFP-expressing MSCs and offer
  an alternative fluorescent MSCs with the following properties:
       •Generated by chemical transfection of CdSe/ZnS nanoparticles, 100 nm in
       diameter
       •Strong fluorescent signal (Exmax= 515 nm; Emissionmax= 520-550 nm)
       detectable by standard FITC filters.
       •Retains fluorescence through growth or differentiation into chondrogenic,
       adipogenic or osteogenic lineages.
       •Possible indicator of endoplasmic processing within MSCs
       •Fluorescence is detectable in three successive passages and diminishes with
       passage.
       •Useful in tracking and imaging investigations based on MSCs
FITC analysis of cells during second passage following transfection. Image obtaining using FITC
filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and
Q-Capture software program. Scale bar is 25 micrometers.
FITC analysis of cells during third passage following transfection. Image obtaining using FITC
filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and Q-
Capture software program. Scale bar is 25 micrometers. Note that this culture is at higher cell
density than the previous image.
FITC analysis of cells during fourth passage following transfection. Image obtaining using FITC
filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and Q-
Capture software program. Scale bar is 25 micrometers. Fluorescent nanoparticles are less
prevalent within the cytoplasm than earlier passages.
Osteogenic differentiation of Grn-fluorescent nanoparticle-labeled MSCs. Image obtaining using phase
contrast Olympus CKX41 microscope at 100 X equipped with a Retiga 2000 digital camera and Q-Capture
Pro software program. Scale bar is 25 micrometers. Note the presence of mineral deposits indicating
differentiation into osteoblasts. Chondrogenic and adipogenic differentiation was also apparent .

More Related Content

More from Pete Shuster

Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Pete Shuster
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012
Pete Shuster
 

More from Pete Shuster (18)

Neuromics base presentation 2020
Neuromics base presentation 2020Neuromics base presentation 2020
Neuromics base presentation 2020
 
Neuromics base presentation 2019
Neuromics base presentation 2019Neuromics base presentation 2019
Neuromics base presentation 2019
 
Human blood brain barrier
Human blood brain barrierHuman blood brain barrier
Human blood brain barrier
 
"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery
 
Poster sot 2015_am_final
Poster sot 2015_am_finalPoster sot 2015_am_final
Poster sot 2015_am_final
 
CELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your AssaysCELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your Assays
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
 
Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13
 
Neuron Glial Interactions
Neuron Glial InteractionsNeuron Glial Interactions
Neuron Glial Interactions
 
Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsOptimized Protocol for Sorting Cells
Optimized Protocol for Sorting Cells
 
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsBiopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
 
Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013
 
Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012
 
Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12
 
Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011
 
Neuromics Presentation V4
Neuromics Presentation V4Neuromics Presentation V4
Neuromics Presentation V4
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 

Recently uploaded

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Victor Rentea
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Victor Rentea
 

Recently uploaded (20)

Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 

Human mesenchymal stem cells green fluorescent nanoparticle-labeled sc00-a4np technical information

  • 1. Introducing: Green Fluorescent Nanoparticle-labeled human Mesenchymal Stem Cells These cells add to our fluorescein, rhodamine and GFP-expressing MSCs and offer an alternative fluorescent MSCs with the following properties: •Generated by chemical transfection of CdSe/ZnS nanoparticles, 100 nm in diameter •Strong fluorescent signal (Exmax= 515 nm; Emissionmax= 520-550 nm) detectable by standard FITC filters. •Retains fluorescence through growth or differentiation into chondrogenic, adipogenic or osteogenic lineages. •Possible indicator of endoplasmic processing within MSCs •Fluorescence is detectable in three successive passages and diminishes with passage. •Useful in tracking and imaging investigations based on MSCs
  • 2. FITC analysis of cells during second passage following transfection. Image obtaining using FITC filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and Q-Capture software program. Scale bar is 25 micrometers.
  • 3. FITC analysis of cells during third passage following transfection. Image obtaining using FITC filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and Q- Capture software program. Scale bar is 25 micrometers. Note that this culture is at higher cell density than the previous image.
  • 4. FITC analysis of cells during fourth passage following transfection. Image obtaining using FITC filter on Olympus CKX41 microscope at 200 X equipped with a Retiga 2000 digital camera and Q- Capture software program. Scale bar is 25 micrometers. Fluorescent nanoparticles are less prevalent within the cytoplasm than earlier passages.
  • 5. Osteogenic differentiation of Grn-fluorescent nanoparticle-labeled MSCs. Image obtaining using phase contrast Olympus CKX41 microscope at 100 X equipped with a Retiga 2000 digital camera and Q-Capture Pro software program. Scale bar is 25 micrometers. Note the presence of mineral deposits indicating differentiation into osteoblasts. Chondrogenic and adipogenic differentiation was also apparent .